Safety and immunogenicity of a live attenuated varicella vaccine in VZV-seropositive HIV-infected adults
2010; Landes Bioscience; Volume: 6; Issue: 4 Linguagem: Inglês
10.4161/hv.6.4.10654
ISSN1554-8619
AutoresAdriana Weinberg, Myron J. Levin, Rob Roy MacGregor,
Tópico(s)Virus-based gene therapy research
ResumoBackground: Herpes-zoster is common in HIV-infected patients in spite of antiretroviral therapy. We evaluated the safety and immunogenicity of a live attenuated varicella-zoster virus (VZV) vaccine as a candidate for protecting HIV-infected adults against herpes-zoster. Methods: HIV-infected adults with CD4 ≥400 cells/µL and plasma HIV RNA
Referência(s)